Fate Therapeutics Inc (NASDAQ:FATE)

23.58
Delayed Data
As of May 27
 +1.15 / +5.13%
Today’s Change
20.49
Today|||52-Week Range
97.43
-59.70%
Year-to-Date
Analysts Tab Veeva Systems as a Top Value Pick
May 25 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close22.43
Today’s open22.68
Day’s range21.74 - 23.70
Volume97,801
Average volume (3 months)1,406,284
Market cap$2.3B
Data as of 4:00pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)-6.39%
Earnings growth (this year)-46.23%
Earnings growth (next 5 years)-36.60%
Revenue growth (last year)+77.66%
P/E ratioNM
Price/Sales99.27
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
ARVNArvinas Inc+1.87+4.53%
----
TLRYTilray Brands Inc-0.12-2.58%
TWSTTwist Bioscience Cor...+1.17+3.37%
Data as of 4:00pm ET, 05/27/2022

Financials

Next reporting dateAugust 9, 2022
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$55.8M
Annual profit (last year)-$212.2M
Net profit margin-379.89%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts